These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34011043)

  • 41. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study.
    Tian Y; Hua H; Peng Q; Zhang Z; Wang X; Han J; Ma W; Chen J
    J Magn Reson Imaging; 2022 Nov; 56(5):1459-1472. PubMed ID: 35298849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
    Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
    J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure.
    Donadon M; Lanza E; Branciforte B; Muglia R; Lisi C; Pedicini V; Poretti D; Famularo S; Balzarini L; Torzilli G
    Surgery; 2020 Sep; 168(3):419-425. PubMed ID: 32600880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation.
    Huang K; Dong Z; Cai H; Huang M; Peng Z; Xu L; Jia Y; Song C; Li ZP; Feng ST
    BMC Cancer; 2019 Apr; 19(1):364. PubMed ID: 30999947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
    Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
    Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v.
    Yao WW; Zhang HW; M YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F
    Technol Cancer Res Treat; 2024; 23():15330338241260331. PubMed ID: 38860337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
    Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
    Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
    Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
    Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
    Zhang L; Yu X; Wei W; Pan X; Lu L; Xia J; Zheng W; Jia N; Huo L
    Eur Radiol; 2020 Oct; 30(10):5327-5336. PubMed ID: 32367417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
    Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
    J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study.
    Rao C; Wang X; Li M; Zhou G; Gu H
    BMC Med Imaging; 2020 Apr; 20(1):43. PubMed ID: 32345247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of nomogram prediction model of contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for vessels encapsulating tumor clusters pattern of hepatocellular carcinoma.
    Wang F; Numata K; Funaoka A; Liu X; Kumamoto T; Takeda K; Chuma M; Nozaki A; Ruan L; Maeda S
    Biosci Trends; 2024 Jul; 18(3):277-288. PubMed ID: 38866488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
    Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Fujita N; Ushijima Y; Ishimatsu K; Okamoto D; Wada N; Takao S; Murayama R; Itoyama M; Harada N; Maehara J; Oda Y; Ishigami K; Nishie A
    Abdom Radiol (NY); 2024 May; 49(5):1467-1478. PubMed ID: 38360959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.